company background image
CAN

Cann Group ASX:CAN Stock Report

Last Price

AU$0.18

Market Cap

AU$71.9m

7D

-5.3%

1Y

-33.3%

Updated

08 Feb, 2023

Data

Company Financials

CAN Stock Overview

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets.

CAN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

New

Notes are coming soon

Cann Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cann Group
Historical stock prices
Current Share PriceAU$0.18
52 Week HighAU$0.43
52 Week LowAU$0.18
Beta1.12
1 Month Change-12.20%
3 Month Change-21.74%
1 Year Change-33.33%
3 Year Change-84.35%
5 Year Change-94.58%
Change since IPO-72.09%

Recent News & Updates

Recent updates

Shareholders May Be A Bit More Conservative With Cann Group Limited's (ASX:CAN) CEO Compensation For Now

Nov 03
Shareholders May Be A Bit More Conservative With Cann Group Limited's (ASX:CAN) CEO Compensation For Now

Here's Why We're Not Too Worried About Cann Group's (ASX:CAN) Cash Burn Situation

Feb 23
Here's Why We're Not Too Worried About Cann Group's (ASX:CAN) Cash Burn Situation

What Type Of Returns Would Cann Group's(ASX:CAN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Nov 25
What Type Of Returns Would Cann Group's(ASX:CAN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

One Forecaster Is Now More Bearish On Cann Group Limited (ASX:CAN) Than They Used To Be

Nov 25
One Forecaster Is Now More Bearish On Cann Group Limited (ASX:CAN) Than They Used To Be

Shareholder Returns

CANAU PharmaceuticalsAU Market
7D-5.3%-1.6%0.4%
1Y-33.3%-31.0%0.4%

Return vs Industry: CAN underperformed the Australian Pharmaceuticals industry which returned -31% over the past year.

Return vs Market: CAN underperformed the Australian Market which returned 0.4% over the past year.

Price Volatility

Is CAN's price volatile compared to industry and market?
CAN volatility
CAN Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement8.4%
10% most volatile stocks in AU Market15.5%
10% least volatile stocks in AU Market3.4%

Stable Share Price: CAN is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: CAN's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aPeter Koetsierhttps://www.canngrouplimited.com

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

Cann Group Limited Fundamentals Summary

How do Cann Group's earnings and revenue compare to its market cap?
CAN fundamental statistics
Market CapAU$71.88m
Earnings (TTM)-AU$26.47m
Revenue (TTM)AU$11.24m

6.2x

P/S Ratio

-2.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CAN income statement (TTM)
RevenueAU$11.24m
Cost of RevenueAU$0
Gross ProfitAU$11.24m
Other ExpensesAU$37.71m
Earnings-AU$26.47m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.068
Gross Margin100.00%
Net Profit Margin-235.52%
Debt/Equity Ratio55.2%

How did CAN perform over the long term?

See historical performance and comparison